The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

The AHA Aug. 27 said the Health Resources and Services Administration should abandon its 340B Rebate Model Pilot Program.

Just days and weeks away from key deadlines, the hospital industry’s leading trade organization is still calling for the administration to scrap a one-year pilot of drugmakers’ preferred approach t | ...

KEY TAKEAWAYS HRSA is launching a voluntary pilot program to test a rebate model for certain 340B drugs, a significant shift from the program's traditional upfront discount structure.

The 340B program is an existing program that allows certain eligible hospitals and other providers to purchase outpatient drugs at a discount from pharmaceutical manufacturers.

The 340B program is not a prescription drug benefit for uninsured or low-income patients. Rather, it allows covered entities enrolled in the program to purchase drugs at the 340B discounted price ...

Misguided eligibility standards and loopholes have allowed 340B hospitals and their associated pharmacies to prioritize profits over patients.

The 340B drug pricing program, originally intended to help low-income and uninsured patients, has been exploited by special interests for profit, resulting in higher drug prices, taxes, and premium… ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992 ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues.